QA: Karuna Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001771917_2021_Karuna_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001771917, Karuna Therapeutics Inc

  xvar xval
0 AssetsCurrent 344,599,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 449,000
3 remainder_Assets 2,577,000
4 LiabilitiesCurrent 6,853,000
5 LiabilitiesNoncurrent 1,841,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 28,408,000
9 ResearchAndDevelopmentExpense 43,408,000
10 remainder_Expenses 43,000
11 remainder_Revenues 0
12 remainder_NetIncome 3,305,000
13 remainder_ComprehensiveNetIncome 34,000
  yvar yval
0 Assets 347,625,000
1 Liabilities 8,694,000
2 Expenses 71,859,000
3 Revenues 0
4 StockholdersEquity 338,931,000
5 NetIncome -68,554,000
6 ComprehensiveNetIncome -68,537,000
7 BaseVar 215,758,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.76
9 EconomicCapitalRatio 4.22

Edgar->Model Mapping

Feature Distribution

Change over Time